
Manufacturing challenges surround the use of IgM monoclonal antibodies, but these can be overcome with current technology.

Published: March 2nd 2008 | Updated:
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
